FDA seeks active system for monitoring adverse events

被引：0
|
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2008年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：14 / +
页数：2
相关论文
共 50 条
  • [21] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [22] Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System
    Swisher, Austin R.
    Kshirsagar, Rijul S.
    Adappa, Nithin D.
    Liang, Jonathan
    LARYNGOSCOPE, 2022, 132 (12): : 2307 - 2313
  • [23] Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System
    Yang, Luxuan
    Zhang, Wenyong
    Shen, Xiujuan
    Liu, Meiqin
    Wu, Meiying
    Xiao, Dan
    DRUG DISCOVERIES AND THERAPEUTICS, 2025,
  • [24] Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system
    Cao, Bing
    Gu, Shanshan
    Shen, Zhisen
    Zhang, Yuna
    Shen, Yiming
    Chen, Hang
    EXPERT OPINION ON DRUG SAFETY, 2023, : 297 - 303
  • [25] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Zou, Shu-peng
    Yang, Hai-yun
    Ouyang, Meng-ling
    Cheng, Qian
    Shi, Xuan
    Sun, Ming-hui
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [26] Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
    Huang, Shulan
    Dong, Hanlin
    Luo, Dongqiang
    Jiang, Jiazhen
    Liu, Manting
    Wu, Jiayu
    Dou, Xiangyun
    Zhou, Siyuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [27] Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
    Mao, Wei
    Jiang, Junyan
    Xia, Yanping
    Zhang, Lin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [28] MONITORING-SYSTEM FOR ADVERSE EVENTS FOLLOWING IMMUNIZATION
    STETLER, HC
    MULLEN, JR
    BRENNAN, JP
    LIVENGOOD, JR
    ORENSTEIN, WA
    HINMAN, AR
    VACCINE, 1987, 5 (03) : 169 - 174
  • [29] ADVERSE EVENTS ASSOCIATED WITH THE DAVINCI SURGICAL SYSTEM AS REPORTED IN THE FDA MAUDE DATABASE
    Gupta, Priyanka
    Schomburg, John
    Lund, Erik
    Adejoro, Olukawayode
    Konety, Badrinath
    JOURNAL OF UROLOGY, 2013, 189 (04): : E351 - E351
  • [30] A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
    Pan, Yunyan
    Wang, Yu
    Zheng, Yifan
    Chen, Jie
    Li, Jia
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345